Evaluating balloon sinuplasty for maxillary sinusitis
Official title: A Placebo Controlled Randomised Study of the Balloon Sinuplasty Efficiency in Chronic or Recurrent Maxillary Rhinosinusitis.
Run by Tampere University Hospital · NCT04645511 · Data updated 2026-11-12
This study is testing if balloon sinuplasty can help people with chronic or recurrent maxillary sinusitis feel better compared to a fake surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 69 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Tampere University Hospital Academic / other |
| Locations | 1 site (Tampere) |
| Status | Recruiting |
| Started | June 1, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | October 20, 2022 |
| Trial ID | NCT04645511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 70 with chronic or recurrent maxillary rhinosinusitis who have not responded to prior corticosteroid treatment.
✕Probably not a fit
Patients with chronic rhinosinusitis accompanied by nasal polyps or significant inflammation in other sinuses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial is a prospective, randomized, placebo-controlled, double-blinded study that aims to assess the efficacy of balloon sinuplasty in treating chronic and recurrent maxillary sinusitis. It involves 120 patients who are divided into two groups based on their condition: chronic maxillary sinusitis and recurrent maxillary sinusitis. Participants will receive either the balloon sinuplasty treatment or a sham surgery to determine the actual benefits of the procedure. The study also seeks to evaluate the impact of the treatment on Eustachian tube dysfunction.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from chronic or recurrent maxillary sinusitis.
How similar studies have gone: Previous studies have shown promising results for balloon sinuplasty in sinusitis treatment, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients at least 18 years old and younger than 70 years old * Patients willing to participate in the study * Patients whose diseases fill the definitions of chronic or acute recurrent maxillary rhinosinusitis * Patients with chronic maxillary rhinosinusitis has not responded to a 3-month trial of topical corticosteroid treatment * SNOT-22 points 8 or more in chronic maxillary rhinosinusitis * In recurrent acute maxillary rhinosinusitis, no SNOT-22 point limits are used * Modified Lund-Mackay inclusion criteria in chronic rhinosinusitis group: 1. Maxillar 0-2 2. Anterior Ethmoid 0-2 3. Posterior Ethmoid 0-1 4. Sphenoid 0-1 5. Frontal 0-1 6. Ostiomeatal complex 0 or 2 Exclusion Criteria: * Chronic rhinosinusitis with nasal polyps * Notable inflammation in the ethmoidal, sphenoidal or frontal sinuses along with maxillary sinusitis * Previous nasal surgery * Sinonasal tumor * Maxillary rhinosinusitis caused by a dental problem * Facial pain caused by other etiologies * Cystic fibrosis * Gross immunodeficiency * Congenital mucociliary problems * Non-invasive fungal balls and invasive fungal disease * Systemic vasculitis and granulomatous disease * Severe systemic diseases * Malignancies * Pregnancy Definitions: Recurrent acute maxillary rhinosinusitis: * 4 or more episodes (\< 12 weeks) of acute rhinosinusitis with typical symptoms per year and no persistent symptoms between the rhinosinusitis episodes (Chan and Kuhn 2009) * The diagnosis of the recurrent episodes of acute rhinosinusitis have been made with the following criteria: * Increase of symptoms after 5 days or persistent symptoms after 10 days and * During the episode, 2 or more symptoms, one of which should be either nasal blockage/obstruction or nasal discharge (anterior/posterior nasal drip) * +/- facial pain/pressure * +/- reduction or loss of smell (Fokkens et al. 2012) and either * Signs of mucopurulent discharge primarily from the middle meatus seen in anterior rhinoscopy or nasoendoscopy and/or * Oedema/mucosal obstruction primarily seen in the middle meatus in anterior rhinoscopy or nasoendoscopy and/or * Signs of mucopurulent discharge seen in the nasopharynx or posterior oropharynx and/or * Signs of acute maxillary sinusitis is seen in sinus X-rays or CT/CBCT scans and/or * Signs of acute maxillary sinusitis seen in the sinus ultrasound * No signs of mucosal disease at nasoendoscopy during the asymptomatic period * At most, minor signs of inflammation in the maxillary sinuses and/or ostiomeatal complex in CT/CBCT scans during the asymptomatic period * Maximum 2-3 mm mucosal thickness in maxillary sinus medial and lateral wall Chronic maxillary rhinosinusitis: * Presence of typical symptoms of chronic rhinosinusitis for equal or longer than 12 weeks * 2 or more symptoms, one of which should be either nasal blockage/obstruction or nasal discharge (anterior/posterior nasal drip) * +/- facial pain/pressure * +/- reduction or loss of smell and either * Endoscopic signs of mucopurulent discharge primarily from middle meatus and/or * Endoscopic signs of oedema/mucosal obstruction primarily in middle meatus and/or * Inflammatory mucosal changes within the ostiomeatal complex and/or sinus in the CT/CBCT scans and the changes are limited mainly into maxillary sinuses (Fokkens et al. 2012) The patients are not recruited in the study while they are having an exacerbation of chronic rhinosinusitis or an ongoing acute rhinosinusitis. Neither are the follow-up visits carried out during these episodes but postponed later. This way it can be ensured that the preoperative evaluation and the follow-up evaluation correspond with each other.
Where it's running
-
Tampere University Hospital
Tampere, Finland Recruiting
Study contacts
- Principal investigator: Johanna Luukkanen, MD — Doctoral thesis researcher
- Study coordinator: Johanna Luukkanen
- Email: johanna.luukkanen@tuni.fi
- Phone: +358407480866
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nasal Dilator Therapy for Patulous Eustachian Tube
This study tests whether wearing a nasal dilator helps reduce symptoms in adults with patulous Eustachian tube dysfunction.
-
Buteyko breathing plus smoking-hygiene for adolescents with passive household smoke exposure and chronic Eustachian tube dysfunction
This project will test whether adding regular Buteyko breathing exercises to smoking-hygiene education helps adolescents exposed to household tobacco smoke who have chronic Eustachian tube dysfunction and reduced lung function.
-
Buteyko breathing for seniors with chronic obstructive Eustachian tube dysfunction
This trial will try adding daily Buteyko breathing exercises to usual care to see if it helps seniors with chronic Eustachian tube dysfunction.
-
Single-step treatment for maxillary sinusitis caused by dental issues
This study is testing a new combined treatment for people with sinus infections caused by dental problems to see if it works better than standard care.
-
Balloon dilation procedure for treating Eustachian tube dysfunction
This study is testing if a balloon dilation procedure can help people with Eustachian tube dysfunction feel better compared to a fake treatment.
-
New nasal spray delivery system for treating Eustachian tube dysfunction
This study tests a new nasal spray to see if it can help people with Eustachian tube dysfunction feel better by delivering medication more effectively.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.